GlassScriptPhysician profile
John Fadel
NPI 1700272499
$906.37
in general payments reported to CMS, 2019-2025
17 companies · $676 in 2025
The $676 reported for 2025 was more than what 80% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.00 · 2021: $28.16 · 2022: $37.24 · 2023: $24.89 · 2024: $127 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.02 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $259.17 | 2025 | Veozah |
| Intuitive Surgical, INC. | $205.01 | 2025 | |
| Janssen Biotech, INC. | $83.98 | 2025 | Balversa, Erleada, Rybrevant |
| Terumo Medical Corporation | $66.67 | 2024 | Tr Band, Navicross, Hydropearl |
| Coopersurgical, INC. | $37.24 | 2022 | |
| Progenics Pharmaceuticals, INC. | $30.50 | 2025 | |
| Abbvie INC. | $28.82 | 2025 | |
| Viiv Healthcare Company | $26.13 | 2025 | Apretude |
| Exeltis, USA INC. | $24.99 | 2025 | Slynd |
| Sumitomo Pharma America, INC. | $24.89 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $21.60 | 2024 | |
| Taiho Oncology, INC. | $21.39 | 2024 | |
| Lilly USA, LLC | $17.53 | 2025 | Mounjaro, Zepbound |
| Stemline Therapeutics INC. | $17.29 | 2024 | Orserdu |
| Merck Sharp & Dohme LLC | $15.38 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.00 | 2019 | |
| Avion Pharmaceuticals | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fadel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.